The present invention relates to anti-SIRP antibodies, as well as use of these antibodies in the treatment of diseases such as cancer and infectious disease.La présente invention concerne des anticorps anti-SIRPα, ainsi que l'utilisation de ces anticorps dans le traitement de maladies telles que le cancer et les maladies infectieuses.